The Morning Filter cover image

5 Stocks to Buy Before They Climb Higher

The Morning Filter

00:00

CRISPR Therapeutics: Gene-Editing Upside with Risk

Susan asks about CRSP; Dave outlines its gene-editing focus, launched sickle cell treatment, cash runway, and long timeline to profitability.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app